No Data
No Data
Goldman Sachs Maintains Baxter International Inc(BAX.US) With Hold Rating, Maintains Target Price $36
Goldman Sachs analyst David Roman maintains $Baxter International Inc(BAX.US)$ with a hold rating, and maintains the target price at $36.According to TipRanks data, the analyst has a success rate of 7
How Is The Market Feeling About Baxter Intl?
Baxter Intl's (NYSE:BAX) short percent of float has fallen 20.54% since its last report. The company recently reported that it has 7.97 million shares sold short, which is 2.05% of all regular shares
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
Express News | NYSE Order Imbalance 192435.0 Shares on Buy Side
Express News | NYSE Order Imbalance 52186.0 Shares on Sell Side
The Most Crowded Longs and Shorts in U.S. Med-Tech for May - UBS
No Data